Treatment Indications: restoration of severe volume loss and deep facial depressions;, structural facial contouring and volumizing in high‑support zones (cheeks, cheekbones, chin, jawline, nasal bridge);, non‑surgical rhinoplasty and sharp facial definition;, correction of deep nasolabial folds and marionette lines; achieving pronounced lifting effect via deep‑layer volumization;, facial symmetry restoration in cases of pronounced atrophy
Release form: 1 × 1.0 mL pre‑filled sterile glass syringe
Indications: deep subcutaneous and supraperiosteal injection for restoration of major volume deficits, facial skeletal support, and structural contouring;, monophasic gel utilizing proprietary HI (High Integration) cross‑linking technology for maximum viscosity, cohesivity, and lifting power with residual BDDE below 0.1 ppm;, providing stable projection, shape retention, and minimal migration (effect duration ~12–18 months)